Mori, K <br/><br/>
Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection.  [electronic resource] 

 -  Journal of virology  Jul 2000 
 - 5747-53 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-538X 
<br/><br/><label>Standard No.: </label>10.1128/jvi.74.13.5747-5753.2000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Viral--blood<br/>Antiviral Agents--therapeutic use<br/>COS Cells<br/>HIV--enzymology<br/>HIV Reverse Transcriptase--antagonists & inhibitors<br/>Humans<br/>Macaca mulatta<br/>Male<br/>Quinoxalines--therapeutic use<br/>Reverse Transcriptase Inhibitors--therapeutic use<br/>Simian Acquired Immunodeficiency Syndrome--blood<br/>Simian Immunodeficiency Virus--genetics<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Time Factors<br/>Viremia